Semaglutide and Pregnancy: When to Stop & "Ozempic Babies"

If you take semaglutide (Wegovy, Ozempic, or Rybelsus) and you are pregnant, trying to conceive, or could become pregnant, this is a high-stakes question that deserves a straight answer rather than reassurance. The short version: the drug's own FDA label tells you to stop it well before a planned pregnancy, and the human safety data in pregnancy is still thin. Here is what the label actually says and what the evidence does — and does not — yet show.

The FDA label is explicit: stop at least 2 months before conceiving

This is the single most important fact, and it comes straight from the manufacturer's FDA prescribing information, not from us. The Wegovy label instructs prescribers to "discontinue WEGOVY in patients at least 2 months before they plan to become pregnant to account for the long half-life of semaglutide"¹.

That two-month buffer is not arbitrary. Semaglutide is a long-acting drug — it is dosed once a week precisely because it lingers in the body — so even after your last injection it takes weeks to clear. Stopping two months ahead is meant to make sure the drug is essentially gone from your system before an embryo begins forming.

The reason the label is cautious is laid out in its own animal-data section. In pregnant rats given semaglutide during organogenesis, the label reports "embryofetal mortality, structural abnormalities and alterations to growth occurred at clinically relevant maternal exposures," and in rabbits and primates "early pregnancy losses and structural abnormalities were observed"¹. These are animal findings, not proof of the same effect in humans — but they are exactly why regulators advise against use in pregnancy until human safety is better established.

What about human pregnancy data?

Here is where honesty matters most: the human evidence is limited and still being assembled, because pregnant women were excluded from the pivotal weight-loss and diabetes trials. What exists so far is reassuring-leaning but not definitive.

A large observational study published in JAMA Internal Medicine looked at GLP-1 receptor agonists used in early pregnancy and did not find a clear signal of increased major birth defects compared with other diabetes treatments — but the authors were careful to frame this as preliminary, not a green light². A separate multicentre observational cohort of GLP-1 use in early pregnancy reached a similarly cautious "no strong alarm, but more data needed" conclusion³. And a 2026 analysis specifically of semaglutide exposure examined gestational weight gain and pregnancy outcomes, again adding to the picture without overturning the label's caution⁴.

The consistent theme across review articles on GLP-1 use in pregnancy is that these drugs are not recommended during pregnancy and should generally be stopped, while acknowledging that accidental early exposure has not, so far, produced an obvious wave of harm in the human data we have⁵. That is genuinely good news for anyone who conceived unexpectedly while on the drug — but it is not the same as the drug being proven safe to use during pregnancy. It is not.

"Ozempic babies": what is actually going on

You may have seen the phrase "Ozempic babies" — stories of people getting pregnant unexpectedly after starting semaglutide, sometimes despite thinking they could not conceive. This is a real, explainable phenomenon, and it is not magic.

Two mechanisms are at work. First, meaningful weight loss can restore ovulation and fertility in people with obesity-related infertility or polycystic ovary syndrome (PCOS), where excess weight had been suppressing regular cycles. Semaglutide produces substantial weight loss — in the pivotal STEP 1 trial, adults lost on average close to 15% of body weight over 68 weeks⁶ — and a return of normal ovulation can follow, raising the odds of conception in someone who had assumed they were infertile⁷. Second, there is a contraception angle that is easy to miss: if you take an oral birth-control pill and the drug's gastrointestinal side effects make you vomit, the pill's absorption can be reduced — a real concern we cover in detail in does semaglutide affect birth control?.

The practical takeaway from "Ozempic babies" is the opposite of a fun headline: if you are on semaglutide and not trying to get pregnant, do not assume your old fertility status still applies. Use reliable contraception, because your fertility may have quietly increased.

What to do if you are trying to conceive

If pregnancy is the goal, the plan is straightforward and should be made with your prescriber: stop semaglutide at least two months before you start trying, per the label¹. That gives the drug time to clear. Because stopping semaglutide commonly leads to weight regain — most people regain a large share of lost weight over the following year, as we explain in what happens if you stop semaglutide? — your clinician can help you plan the transition and discuss how to manage weight and any underlying diabetes during the conception window and pregnancy.

For people with type 2 diabetes, this is especially important: blood sugar still needs managing in pregnancy, just with pregnancy-appropriate treatments. Major endocrine-society guidance on diabetes in pregnancy reflects this shift toward established, pregnancy-safe options rather than GLP-1 drugs⁸.

What to do if you find out you are already pregnant on semaglutide

Do not panic, and do not double down. If you discover you are pregnant while taking semaglutide, contact your prescriber promptly. The standard advice is to stop the drug, but the reassuring framing from the human data so far is that an accidental early exposure has not been linked to an obvious surge in birth defects in the available studies²³. Your clinician can weigh your specific situation, switch you to pregnancy-appropriate care, and arrange appropriate monitoring. The goal is calm, prompt action — not alarm.

The bottom line

Semaglutide and pregnancy do not mix under current guidance. The FDA label is unambiguous: stop at least two months before trying to conceive, because the drug is long-acting and animal studies showed embryofetal harm¹. Human data is limited but so far has not flagged an obvious birth-defect signal from early accidental exposure²³ — reassuring, but not a license to use it in pregnancy. And the "Ozempic babies" stories are a real warning that fertility can return with weight loss⁷, so contraception matters more than ever while you are on the drug. For the full evidence picture on the medication itself, see our pillar guide, Semaglutide: How It Works, Results & Side Effects; to compare the providers who prescribe it, see our guide to the best semaglutide options. None of this replaces a conversation with your own prescriber, who should guide any decision about stopping, conceiving, or continuing care.